Mainland media noted that Pfizer’s Paxlovid has been approved in China, along with Genuine Biotech’s Azvudine. Zhejiang Huahai Pharmaceutical (600521 CH) will make the drug for Pfizer.

TASS/. The Health Insurance Administration of South China's Hainan Province has temporarily included the country's oral anti-Covid drug Azvudine into the list of medicine covered by medical insurance.

China will include two other COVID-19 drugs, the Chinese-made antiviral Azvudine and the Chinese herbal blend medicine Qingfei Paidu Granules, the National Healthcare Security Administration said ...